Gilbert Schönfelder

Christopher Weidner¹, 

Matthias Steinfath¹, 

Elisa Wistorf¹, 

Michael Oelgeschläger¹, 

Marlon R. Schneider¹, 

Gilbert Schönfelder^1,2 

¹Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), 

²Department of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin 

Natascha Drude¹, 

Kai Diederich², 

Claudia U. Duerr³, 

Nadine Haase⁴, 

Christoph Harms^5,6,7,8, 

Frank Heppner^9,10,11, 

Marina Jendrach^9,10,11, 

Pia Kahnau², 

Marina Kolesnichenko¹², 

Lars Lewejohann^2,13, 

Claudia Kurreck¹, 

Anke Lohan¹⁴, 

Marcus A. Mall^15,16, 

Dominik Müller⁴, 

Stefan Nagel-Riedasch¹⁴, 

Bastian Opitz¹⁷, 

Laura Schaupp^15,16, 

Gilbert Schönfelder^2,18, 

Amelie Weber³, 

Gerald Willimsky^19,20,21, 

Yalei Zang^1,22, 

Stephan P. Rosshart^*,23,24, 

Andreas Diefenbach^*,3, 

Stefan Jordan^*,3 

¹BIH QUEST Center for Responsible Research, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 

²German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R), 

³Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

⁴, Experimental and Clinical Research Center (ECRC) & Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), 

⁵Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik und Hochschulambulanz für Neurologie, 

⁶Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

⁷, Einstein Center for Neuroscience, 

⁸, German Center for Cardiovascular Research (DZHK), partner site Berlin, 

⁹Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

¹⁰, Cluster of Excellence, NeuroCure, 

¹¹, German Center for Neurodegenerative Diseases (DZNE) Berlin, 

¹²Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

¹³Institute of Animal Welfare, Animal Behavior and Laboratory Animal Science, Freie Universität Berlin, 

¹⁴Forschungseinrichtungen für Experimentelle Medizin/FEM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

¹⁵Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

¹⁶, German Center for Lung Research (DZL), associated partner site, Berlin, 

¹⁷Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

¹⁸Division of Toxicology, Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 

¹⁹Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

²⁰, German Cancer Research Center, 

²¹, German Cancer Consortium, partner site Berlin, 

²²Department of Radiology (including Pediatric Radiology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 

²³Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 

²⁴Department of Medicine II, Faculty of Medicine, Medical Center - University of Freiburg